Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Boston Scientific and raises the price target from $90 to $92.
August 22, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch has reiterated a Buy rating for Boston Scientific and increased the price target from $90 to $92, indicating a positive outlook.
The increase in the price target from $90 to $92 by Citigroup suggests a positive outlook for Boston Scientific. This is likely to boost investor confidence and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100